K Enright1, T Desai2, R Sutradhar2,3, A Gonzalez3, M Powis4, N Taback2, C M Booth5, M E Trudeau6, M K Krzyzanowska3,4. 1. Carlo Fidani Regional Cancer Centre, Trillium Health Partners- Credit Valley Hospital, Mississauga, ON. 2. University of Toronto, Toronto, ON. 3. Institute for Clinical Evaluative Sciences, Toronto, ON. 4. Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON. 5. Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, ON. 6. Sunnybrook Health Sciences Centre, Toronto, ON.
Abstract
Background: Overuse of surveillance imaging in patients after curative treatment for early breast cancer (ebc) was recently identified as one of the Choosing Wisely Canada initiatives to improve the quality of cancer care. We undertook a population-level examination of imaging practices in Ontario as they existed before the launch of that initiative. Methods: Patients diagnosed with ebc between 2006 and 2010 in Ontario were identified from the Ontario Cancer Registry. Records were linked deterministically to provincial health care databases to obtain comprehensive follow-up. We identified all advanced imaging exams [aies: computed tomography (ct), bone scan, positron-emission tomography] and basic imaging exams (bies: ultrasonography, chest radiography) occurring within the first 2 years after curative treatment. Poisson regression was used to assess associations between patient or provider characteristics and the rate of aies. Results: Of 30,006 women with ebc, 58.6% received at least 1 bie, and 30.6% received at least 1 aie in year 1 after treatment. In year 2, 52.7% received at least 1 bie, and 25.7% received at least 1 aie. The most common aies were chest cts and bone scans. The rate of aies increased with older age, higher disease stage, comorbidity, chemotherapy exposure, and prior staging investigations (p < 0.001). Imaging was ordered mainly by medical oncologists (38%), followed by primary care physicians (23%), surgeons (13%), and emergency room physicians (7%). Conclusions: Despite recommendations against its use, imaging is common in ebc survivors. Understanding the factors associated with aie use helps to identify areas for further research and is required to lower imaging rates and to improve survivorship care.
Background: Overuse of surveillance imaging in patients after curative treatment for early breast cancer (ebc) was recently identified as one of the Choosing Wisely Canada initiatives to improve the quality of cancer care. We undertook a population-level examination of imaging practices in Ontario as they existed before the launch of that initiative. Methods:Patients diagnosed with ebc between 2006 and 2010 in Ontario were identified from the Ontario Cancer Registry. Records were linked deterministically to provincial health care databases to obtain comprehensive follow-up. We identified all advanced imaging exams [aies: computed tomography (ct), bone scan, positron-emission tomography] and basic imaging exams (bies: ultrasonography, chest radiography) occurring within the first 2 years after curative treatment. Poisson regression was used to assess associations between patient or provider characteristics and the rate of aies. Results: Of 30,006 women with ebc, 58.6% received at least 1 bie, and 30.6% received at least 1 aie in year 1 after treatment. In year 2, 52.7% received at least 1 bie, and 25.7% received at least 1 aie. The most common aies were chest cts and bone scans. The rate of aies increased with older age, higher disease stage, comorbidity, chemotherapy exposure, and prior staging investigations (p < 0.001). Imaging was ordered mainly by medical oncologists (38%), followed by primary care physicians (23%), surgeons (13%), and emergency room physicians (7%). Conclusions: Despite recommendations against its use, imaging is common in ebc survivors. Understanding the factors associated with aie use helps to identify areas for further research and is required to lower imaging rates and to improve survivorship care.
Entities:
Keywords:
Early breast cancer; curative treatment; imaging overuse
Authors: Li Jiang; Aisha Lofters; Rahim Moineddin; Kathleen Decker; Patti Groome; Cynthia Kendell; Monika Krzyzanowska; Dongdong Li; Mary L McBride; Nicole Mittmann; Geoff Porter; Donna Turner; Robin Urquhart; Marcy Winget; Yang Zhang; Eva Grunfeld Journal: Can Fam Physician Date: 2016-10 Impact factor: 3.275
Authors: William R Hendee; Gary J Becker; James P Borgstede; Jennifer Bosma; William J Casarella; Beth A Erickson; C Douglas Maynard; James H Thrall; Paul E Wallner Journal: Radiology Date: 2010-08-24 Impact factor: 11.105
Authors: Aaron J Dawes; Marian Hemmelgarn; David K Nguyen; Greg D Sacks; Sheilah M Clayton; Jacqueline R Cope; Patricia A Ganz; Melinda Maggard-Gibbons Journal: Cancer Date: 2014-12-23 Impact factor: 6.860
Authors: N Mittmann; J M Porter; J Rangrej; S J Seung; N Liu; R Saskin; M C Cheung; N B Leighl; J S Hoch; M Trudeau; W K Evans; K N Dainty; C DeAngelis; C C Earle Journal: Curr Oncol Date: 2014-12 Impact factor: 3.677
Authors: Julie A Margenthaler; Emad Allam; Ling Chen; Katherine S Virgo; Udayan Mayur Kulkarni; Anand P Patel; Frank E Johnson Journal: J Oncol Pract Date: 2011-12-13 Impact factor: 3.840
Authors: James L Khatcheressian; Patricia Hurley; Elissa Bantug; Laura J Esserman; Eva Grunfeld; Francine Halberg; Alexander Hantel; N Lynn Henry; Hyman B Muss; Thomas J Smith; Victor G Vogel; Antonio C Wolff; Mark R Somerfield; Nancy E Davidson Journal: J Clin Oncol Date: 2012-11-05 Impact factor: 44.544
Authors: Corinne Daly; David R Urbach; Thérèse A Stukel; Paul C Nathan; Wayne Deitel; Lawrence F Paszat; Andrew S Wilton; Nancy N Baxter Journal: BMC Cancer Date: 2015-09-03 Impact factor: 4.430
Authors: Hely Shah; Julian Surujballi; Arif Ali Awan; Brian Hutton; Angel Arnaout; Risa Shorr; Lisa Vandermeer; Mashari Jemaan Alzahrani; Mark Clemons Journal: Breast Cancer Res Treat Date: 2020-11-06 Impact factor: 4.872
Authors: Amir Alishahi Tabriz; Kea Turner; Alecia Clary; Young-Rock Hong; Oliver T Nguyen; Grace Wei; Rebecca B Carlson; Sarah A Birken Journal: Implement Sci Date: 2022-03-12 Impact factor: 7.327